News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
755,546 Results
Type
Article (61338)
Company Profile (487)
Press Release (693721)
Multimedia
Podcasts (125)
Webinars (13)
Section
Business (210901)
Career Advice (3298)
Deals (36295)
Drug Delivery (127)
Drug Development (85214)
Employer Resources (184)
FDA (17449)
Job Trends (15892)
News (360698)
Policy (36062)
Tag
Academia (2930)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (94)
Alliances (53627)
ALS (97)
Alzheimer's disease (1484)
Antibody-drug conjugate (ADC) (150)
Approvals (17417)
Artificial intelligence (300)
Autoimmune disease (27)
Automation (16)
Bankruptcy (351)
Best Places to Work (12454)
BIOSECURE Act (20)
Biosimilars (118)
Biotechnology (357)
Bladder cancer (83)
Brain cancer (31)
Breast cancer (299)
Cancer (2403)
Cardiovascular disease (200)
Career advice (2792)
Career pathing (34)
CAR-T (172)
Cell therapy (484)
Cervical cancer (21)
Clinical research (68864)
Collaboration (904)
Compensation (525)
Complete response letters (30)
COVID-19 (2826)
CRISPR (48)
C-suite (262)
Cystic fibrosis (107)
Data (2255)
Decentralized trials (2)
Denatured (45)
Depression (51)
Diabetes (294)
Diagnostics (6751)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (136)
Drug pricing (123)
Drug shortages (33)
Duchenne muscular dystrophy (101)
Earnings (84972)
Editorial (44)
Employer branding (23)
Employer resources (160)
Events (123459)
Executive appointments (768)
FDA (18760)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (807)
Gene editing (118)
Generative AI (30)
Gene therapy (355)
GLP-1 (835)
Government (5053)
Grass and pollen (6)
Guidances (62)
Healthcare (20479)
Huntington's disease (23)
IgA nephropathy (30)
Immunology and inflammation (143)
Indications (30)
Infectious disease (2980)
Inflammatory bowel disease (151)
Inflation Reduction Act (11)
Influenza (56)
Intellectual property (100)
Interviews (639)
IPO (16826)
IRA (49)
Job creations (3929)
Job search strategy (2286)
Kidney cancer (11)
Labor market (36)
Layoffs (530)
Leadership (24)
Legal (8503)
Liver cancer (81)
Lung cancer (342)
Lymphoma (158)
Machine learning (7)
Management (64)
Manufacturing (345)
MASH (74)
Medical device (14261)
Medtech (14266)
Mergers & acquisitions (20049)
Metabolic disorders (776)
Multiple sclerosis (87)
NASH (22)
Neurodegenerative disease (111)
Neuropsychiatric disorders (33)
Neuroscience (2078)
NextGen: Class of 2025 (7361)
Non-profit (4888)
Now hiring (36)
Obesity (419)
Opinion (272)
Ovarian cancer (77)
Pain (98)
Pancreatic cancer (83)
Parkinson's disease (160)
Partnered (22)
Patents (248)
Patient recruitment (113)
Peanut (51)
People (60061)
Pharmaceutical (99)
Pharmacy benefit managers (21)
Phase I (21382)
Phase II (30096)
Phase III (22827)
Pipeline (1239)
Policy (165)
Postmarket research (2903)
Preclinical (9292)
Press Release (72)
Prostate cancer (113)
Psychedelics (37)
Radiopharmaceuticals (269)
Rare diseases (428)
Real estate (6380)
Recruiting (73)
Regulatory (24801)
Reports (40)
Research institute (2600)
Resumes & cover letters (521)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (80)
Series A (142)
Series B (91)
Service/supplier (14)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (161)
Sponsored (34)
Startups (3834)
State (2)
Stomach cancer (16)
Supply chain (75)
Tariffs (45)
The Weekly (78)
Vaccines (785)
Venture capitalists (43)
Weight loss (298)
Women's health (40)
Worklife (20)
Date
Today (175)
Last 7 days (903)
Last 30 days (2797)
Last 365 days (34953)
2025 (11367)
2024 (37426)
2023 (42157)
2022 (53478)
2021 (58213)
2020 (57002)
2019 (50338)
2018 (38220)
2017 (35427)
2016 (35649)
2015 (41326)
2014 (34575)
2013 (30110)
2012 (31928)
2011 (31989)
2010 (29919)
Location
Africa (1026)
Alabama (59)
Alaska (7)
Arizona (219)
Arkansas (14)
Asia (44592)
Australia (7545)
California (6322)
Canada (2044)
China (556)
Colorado (279)
Connecticut (298)
Delaware (153)
Europe (102250)
Florida (931)
Georgia (218)
Hawaii (1)
Idaho (62)
Illinois (608)
India (29)
Indiana (324)
Iowa (12)
Japan (167)
Kansas (107)
Kentucky (26)
Louisiana (13)
Maine (70)
Maryland (946)
Massachusetts (4872)
Michigan (244)
Minnesota (405)
Mississippi (2)
Missouri (91)
Montana (29)
Nebraska (26)
Nevada (64)
New Hampshire (70)
New Jersey (1800)
New Mexico (31)
New York (1797)
North Carolina (1097)
North Dakota (9)
Northern California (2722)
Ohio (217)
Oklahoma (15)
Oregon (38)
Pennsylvania (1403)
Puerto Rico (13)
Rhode Island (34)
South America (1387)
South Carolina (23)
South Dakota (1)
Southern California (2349)
Tennessee (102)
Texas (922)
United States (24234)
Utah (191)
Virginia (158)
Washington D.C. (65)
Washington State (591)
West Virginia (3)
Wisconsin (61)
755,546 Results for "the medicines and healthcare products regulatory agency mhra".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA)
March 11, 2025
·
3 min read
Press Releases
OS Therapies Schedules United Kingdom’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Scientific Advice Meeting in the Third Quarter of 2025 for Review of its OST-HER2 Immunotherapy Candidate for Osteosarcoma
March 11, 2025
·
4 min read
Press Releases
Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine
February 28, 2025
·
4 min read
Press Releases
UK Medicines and Healthcare Products Regulatory Agency Confirms Acceptance of Marketing Authorization Application for Proposed Biosimilar to Xolair® (omalizumab)
March 26, 2025
·
8 min read
Press Releases
BEYONTTRA® (acoramidis), the First Near-complete TTR Stabilizer (≥90%), Approved by the UK Medicines and Healthcare Products Regulatory Agency to Treat ATTR-CM
April 28, 2025
·
10 min read
Press Releases
UK Medicines and Healthcare Products Regulatory Agency has Validated and Accepted the Marketing Authorization Application for ADL-018, a Proposed Biosimilar of Xolair® (omalizumab)
March 27, 2025
·
2 min read
Press Releases
Moderna Receives Medicines And Healthcare Products Regulatory Agency (MHRA) Authorization For Updated COVID-19 Vaccine Targeting SARS-COV-2 Variant JN.1
September 3, 2024
·
4 min read
Press Releases
ImmunityBio Announces UK Medicines and Healthcare Products Regulatory Agency Accepted Marketing Authorization Application for ANKTIVA® for the Treatment of Patients with BCG-unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma In Situ
February 14, 2025
·
9 min read
Biotech Beach
Sentynl Therapeutics Receives MHRA Authorization of NULIBRY® (fosdenopterin) for Treatment of MoCD Type A in Great Britain
Sentynl Therapeutics, Inc. (Sentynl), a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences, Ltd. (Zydus Group), today announced The Medicines and Healthcare products Regulatory Agency (MHRA) authorization of NULIBRY.
April 16, 2024
·
6 min read
GLP-1
UK’s MHRA Finds No Risk of Suicidal Ideation, Self-Harm With GLP-1 Drugs
Like its U.S. and European counterparts, Britain’s Medicines and Healthcare Products Regulatory Agency found no conclusive link between the use of GLP-1s and a heightened risk of suicidal and self-injury thoughts.
September 5, 2024
·
2 min read
·
Tristan Manalac
1 of 75,555
Next
